Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice

Cancer Research

Volumn 61, Issue 3, 2001, Pages 984-990

  Ha, Hye Yeong ^a   Moon, Hyung Bae ^c   Nam, Myoung Soo ^a   Lee, Jeong Woong ^b   Ryoo, Zae Yoong ^b   Lee, Tae Hoon ^a   Lee, Kyung Kwang ^a   So, Byung Jan ^c   Sato, Hiroshi ^d   Seiki, Motoharu ^e   Yu, Dae Yeul ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Wonkwang University   (South Korea)

^d KANAZAWA UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CASEIN; INTERSTITIAL COLLAGENASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; GENE OVEREXPRESSION; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANIMALS; CASEINS; ENZYME ACTIVATION; ENZYME PRECURSORS; FEMALE; GELATINASES; GENE EXPRESSION; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED ICR; MICE, TRANSGENIC; PRECANCEROUS CONDITIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0035110730     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis
2. Tumor cell interactions with the extracellular matrix during invasion and metastasis
3. Type IV collagenase in invasive tumor
4. Metalloproteinases and their inhibitors in matrix remodeling
5. Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis
6. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
7. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis
8. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
9. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy
10. A matrix metalloproteinase expressed on the surface of invasive tumor cells
11. cDNA sequence and mRNA tissue distribution of novel human matrix metalloproteinase with a potential transmembrane segment
12. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family
13. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma
14. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP
15. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors
16. Tumour biology. Membrane proteases in focus
17. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme
18. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis
19. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
20. MT1-MMP deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
21. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinoma
22. Expression of membrane-type metalloproteinase in human gastric carcinoma
23. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinoma correlates with the expression of membrane-type metalloproteinase (MT-MMP) and with lymph node metastasis
24. Dual over-expression pattern of membrane-type metalloproteianse-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy
25. Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumor virus chimaeric plasmids
26. The mammary pathology of genetically engineered mice: The consensus report and recommendation from the Annapolis meeting
27. Membrane-type matrix metalloproteinases
28. Expression of matrix metalloproteinases during rat skin wound healing: Evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase
29. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells
30. Stromal involvement in malignant growth
31. Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma
32. The tumor promoting effect of wounding: A possible role for TGF-β-induced stromal alterations
33. Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction
34. Radial scars in benign breast-biopsy specimen and the risk of breast cancer
35. A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria
36. Landscaping the cancer terrain
37. Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia
38. Expression of autoactivated strymelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development
39. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro
40. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples
41. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase inhibitor-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
42. Activity of type IV collagenases in benign and malignant breast disease
43. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase
44. Association between expression of 72-kilodalton gelatinase and tumor spreads in non-small cell lung carcinoma
45. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: Associated activation of gelatinase A, gelatinase B, and collagenase B
46. Mechanisms for pro matrix metalloproteinase activation
47. Membrane-type metalloproteinase 1 and 2 exhibit broad spectrum proteolytic capacities comparable to many matrix metalloproteinase
48. The matrix metalloproteinase stromelysin-1 acts as a natural tumor promoter
49. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis